Recent

% | $
Quotes you view appear here for quick access.

Novadel Pharma Inc. Message Board

  • leonia5pbb leonia5pbb Mar 4, 2013 4:59 PM Flag

    "Duromist" is a spray form of Viagra, worth many millions of dollars in potential revenue

    From a previous press report:

    "A ‘Viagra spray’ has passed through trials successfully."

    "Experts from NovaDel compared a spray form of sildenafil (the active ingredient in Viagra) to Viagra tablets themselves. Just two sprays of DuroMist were found to have similar effects to a 25mg Viagra pill."

    "But a Viagra spray could have many advantages over a tablet. Because a spray gets into the bloodstream quicker, sildenafil could work faster when applied this way, and it could also be more convenient and discreet for the user."

    Duromist so far as been shown to be very safe and very effective in clinical trials and could generate many millions of dollars in NEW revenue for NVDL in the future.

    Viagra in pill form has generated MORE than 2 billion dollars in total revenue since it was first marketed.
    It is only logical to assume that a "spray mist form of Viagra" can generate many millions of dollars in revenue.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Totally worthless or the PPS would not be a penny

    • NovaDel Pharma Inc. Awarded $244,479 Grant from Qualifying Therapeutic
      Discovery Project Program

      Business Wire

      BRIDGEWATER, N.J. -- November 03, 2010

      NovaDel Pharma Inc. (OTCBB: NVDL), a specialty pharmaceutical company
      developing oral spray formulations for a broad range of marketed
      pharmaceutical products, today announced that it has been awarded a $244,479
      grant under the IRS’ Qualifying Therapeutic Discovery Project, which it
      expects to receive in January 2011. The grant, which targets therapeutic
      discovery projects that show a reasonable potential to result in new therapies
      to treat areas of unmet medical need or to treat chronic or acute diseases and
      conditions or to result in reduced health care costs, was awarded to NovaDel
      to help fund the further clinical development of Duromist™. Duromist is
      NovaDel’s oral spray formulation of sildenafil, and is being developed for the
      treatment of erectile dysfunction.

      ”We are delighted that the potential advantages of Duromist have been
      recognized through the award of this grant,” commented Craig Johnson, Senior
      Vice President and CFO of NovaDel Pharma Inc.

      (....Even if the Grant money is now gone meaning NVDL no longer has it just the fact that NVDL was awarded a Grant shows that there is something great there with Duromist that would cause a Grant to be given in the first place. They just don't hand out those kind of Grants out for no reason.....)

 
NVDL
0.01020.0000(0.00%)Feb 11 3:53 PMEST